Sandoz U.S. subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffsSandoz U.S. to pay $265 million in exchange for full release of all claims by the class. Sandoz closing Fougera facilities on Long Island, N.Y.Sandoz is closing the Fougera manufacturing and packaging facilities located in Melville and Hicksville on Long Island, N.Y. Walgreens’ VillageMD to close all Illinois clinics The clinics are set to close on April 19. Quest Products acquires Tec Labs Quest will add the Tecnu and Licefreee brands. Alvotech, Teva obtain FDA OK for Humira biosimilar Simlandi is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the United States. DOJ launches antitrust investigation into UnitedHealth Group The Department of Justice has opened an antitrust investigation into UnitedHealth Group, the Wall Street Journal reports. IQVIA report sizes up trends in new drug launches, clinical trials, R&D funding R&D funding levels have rebounded in 2023 after a steep decline from the peak seen in 2020-21, per IQVIA's report. Nickel and dimed Rock-bottom pricing and product shortages are placing increasing pressures on the generic drug sector. FTC sues to block Kroger’s acquisition of Albertsons The FTC alleges that the largest supermarket merger in U.S. history will eliminate competition and raise grocery prices for millions of Americans, while harming tens of thousands of workers. Walgreens closing all VillageMD primary care clinics in Florida Walgreens-backed VillageMD is closing all its medical clinics in Florida, one of its biggest markets, per a Business Insider report. First Previous 26 27 28 29 30 Next Last
